文献速递肝病

常见变异型免疫缺陷相关门窦血管病所致肝纤维化进展研究

Development of hepatic fibrosis in common variable immunodeficiency-related porto-sinusoidal vascular disorder.
PubMed 文献 · Aliment Pharmacol Ther · 2024-08-01

回顾性分析美国国立卫生研究院1990至2020年随访的40例常见变异型免疫缺陷(CVID)相关肝病并接受肝活检的患者,中位初次活检年龄37.5岁,73%有结节性再生性增生(NRH)明确证据,中位纤维化分期1期;5年门脉高压累积发生率65%;16例随访肝活检中31%纤维化分期增加≥2期,总体分期增至2.2(p=0.001)。

要点

  • CVID相关肝病最常见初始组织学表现为NRH,本队列占73%。
  • 5年门脉高压累积发生率为65%,中位肝静脉压力梯度9.5 mmHg。
  • 随访肝活检中31%患者纤维化分期增加≥2期,中位随访3年。

核心结论

  • 在本CVID队列中,NRH是最常见的初始组织学表现,但一部分患者纤维化随时间进展。
  • 更好地理解CVID肝病潜在因果过程可能改善结局。

研究设计与样本

  • 回顾性 review 美国国立卫生研究院1990至2020年随访的CVID相关肝病且接受肝活检的患者。
  • 记录临床、影像学和组织学随访作为临床研究方案的一部分。

主要发现

  • 共纳入40例患者,初次活检中位年龄37.5岁,73%有NRH明确证据,中位纤维化分期1期。
  • 活检时中位血小板计数100 × 109/L,脾脏大小19.5 cm,肝静脉压力梯度9.5 mmHg,37.5%患者有门脉高压体征。
  • 5年门脉高压累积发生率为65%。
  • 16例患者随访肝活检中位时间3年,31%纤维化分期增加≥2期,总体分期增至2.2(p=0.001)。
  • 未发现与纤维化进展相关的临床或组织学因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Liver involvement is an increasingly recognised complication of common variable immunodeficiency (CVID). Nodular regenerative hyperplasia (NRH), a subgroup of porto-sinusoidal vascular disorder, and manifestations of portal hypertension (PH) unrelated to cirrhosis are the most common findings. Nonetheless, the evolution of liver disease over time remains unknown. METHODS: Retrospective review of patients followed at the National Institutes of Health with CVID-related liver disease and liver biopsy from 1990 to 2020. Clinical, imaging and histological follow-up were recorded as part of clinical research protocols. RESULTS: Forty patients were included, with a median age of 37.5 years at initial biopsy, 73% presenting with clear evidence of NRH, and a median fibrosis stage of 1. At biopsy, median platelet count was 100 × 109/L, spleen size 19.5 cm, hepatic venous pressure gradient 9.5 mmHg and 37.5% of patients had signs of PH. Cumulative incidence of PH was 65% at 5 years. In a subgroup of 16 patients, a follow-up liver biopsy, performed at a median time of 3 years after the index biopsy, revealed an increase in fibrosis by ≥2 stages in 31% of cases and an increase to an overall stage of 2.2 (p = 0.001). No clinical or histological factors were associated with progression of fibrosis. CONCLUSIONS: In this CVID cohort, NRH is the most common initial histological finding; however, unexpectedly fibrosis progresses over time in a subgroup of patients. A better understanding of the underlying causal process of liver disease CVID might lead to improved outcomes.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Hercun J, Asif B, Vittal A, et al. Development of hepatic fibrosis in common variable immunodeficiency-related porto-sinusoidal vascular disorder. Aliment Pharmacol Ther. 2024. PMID: 39090843. doi:10.1111/apt.18180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。